NCT01354977 Effect of Resveratrol on Age-related Insulin Resistance and Inflammation in Humans Status COMPLETED Phase PHASE2
NCT01353469 Assessment of Efficacy and Safety of Insuman Comb 25 Versus Novolin® 30R Twice Daily Over 24 Weeks in Type 2 Diabetes Patients With Insulin Therapy Status COMPLETED Phase PHASE3
NCT01344928 The Effects of Short-time High-intensity Interval Training on Tissue Glucose and Fat Metabolism in Healthy Subjects and Patients With Type 2 Diabetes Status UNKNOWN Phase NA
NCT01341067 Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes Status COMPLETED Phase N/A
NCT01340768 Study to Compare Sitagliptin Versus Sulfonylurea Treatment During Ramadan Fasting in Patients With Type 2 Diabetes (MK-0431-262) Status COMPLETED Phase PHASE3
NCT01337440 Efficacy and Safety of Ursodeoxycholic Acid (UDCA) Added to the DPP-4 Inhibitor in People With Type 2 Diabetes and Chronic Liver Diseases Status UNKNOWN Phase PHASE4
NCT01334229 Sitagliptin and Kinetics of Triglyceride-rich Lipoproteins Apolipoprotein B48 and B100 in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01334203 A Study on the Effects of Ranolazine on Exercise Duration in Subjects With Chronic Stable Angina and Coronary Artery Disease (CAD) With Type 2 Diabetes Mellitus (T2DM) Status WITHDRAWN Phase PHASE4
NCT01326598 Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting Status COMPLETED Phase N/A
NCT01323114 The Surgical Treatment of Type 2 Diabetes Mellitus in Non-Morbidly Obese Patients: A Community Hospital Study Status UNKNOWN Phase NA
NCT01322711 Atorvastatin, Aspirin, Oxidative Stress, Coagulation and Platelet Activation Indexes Status UNKNOWN Phase PHASE4
NCT01319734 Vitamin C Supplementation Plus Hypoglycemic Agents Versus Hypoglycemic Agents Alone in Type 2 Diabetes Mellitus Status UNKNOWN Phase PHASE1
NCT01318135 Long-term Safety Study of Alogliptin Used in Combination With Sulfonylurea or Metformin in Participants With Type 2 Diabetes in Japan Status COMPLETED Phase PHASE2/PHASE3
NCT01318122 Long-term Safety Study of Alogliptin Used in Combination With Thiazolidine in Participants With Type 2 Diabetes in Japan Status COMPLETED Phase PHASE2/PHASE3
NCT01318109 Efficacy and Safety of Alogliptin Used Combination With Metformin in Participants With Type 2 Diabetes in Japan Status COMPLETED Phase PHASE2/PHASE3
NCT01318083 Efficacy and Safety of Alogliptin Used in Combination With Sulfonylurea in Participants With Type 2 Diabetes in Japan Status COMPLETED Phase PHASE2/PHASE3